BioSpace News Archive

Drug Development

NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)'s Lead Aganocide Compound, NVC-422, Well Tolerated in the Bladder in Phase I Trial

May 12, 2008
·
6 min read
Drug Development

Medarex, Inc. Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis

May 12, 2008
·
5 min read
FDA

Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse(TM)

May 12, 2008
·
4 min read
Drug Development

Starpharma Holdings Ltd Reports Positive VivaGel(R) Clinical Study Results

May 12, 2008
·
3 min read
Drug Development

Novelos Therapeutics, Inc. Announces Positive Results in Ongoing Phase 2 Neoadjuvant Breast Cancer Trial at MUSC Hollings Cancer Center

May 12, 2008
·
6 min read
Business

Cytochroma Inc. Appoints R. Richard Wieland II As CFO

May 12, 2008
·
3 min read
Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference

May 12, 2008
·
2 min read
Business

SpineMark Appoints Wendy L. Wilts as EVP of Operations Key Executive Hire Supports Company’s Continued Growth

May 12, 2008
·
3 min read
Business

Graceway Pharmaceuticals, LLC Teams With Vivacare(SM) on Direct-to-Patient Communication for Dermatology Products

May 12, 2008
·
4 min read
Drug Development

Tengion Inc. to Present Preclinical Data For Regeneration of Entire Bladder Preclinical Results to be Presented During May 18 Press Briefing and Poster Session

May 12, 2008
·
1 min read